{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T16:32:23Z","timestamp":1747067543615},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,25]]},"DOI":"10.7759\/cureus.14673","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T11:43:14Z","timestamp":1619350994000},"source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Efficacy of Difluprednate 0.05% Versus Prednisolone Acetate 1% in Controlling Inflammation and Macular Oedema Following Phacoemulsification: An Optical Coherence Tomography-Based Study"],"prefix":"10.7759","author":[{"given":"Bijnya B","family":"Panda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh C","family":"Swain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015870","article-title":"Torsional and burst mode phacoemulsification for patients with hard nuclear cataract: a randomized control study","volume":"98","author":"Yang WJ","year":"2019","unstructured":"Yang WJ, Wang XH, Zhao F, Mei ZM, Li S, Xiang Y. Torsional and burst mode phacoemulsification for patients with hard nuclear cataract: a randomized control study. Medicine (Baltimore). 2019, 98:e15870. 10.1097\/MD.0000000000015870","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000407","article-title":"Comparison of efficacy of difluprednate 0.05% and loteprednol gel 0.5% after cataract surgery","volume":"44","author":"Abessi B","year":"2018","unstructured":"Abessi B, Brooksby L, Schultze RL. Comparison of efficacy of difluprednate 0.05% and loteprednol gel 0.5% after cataract surgery. Eye Contact Lens. 2018, 44:S37-42. 10.1097\/ICL.0000000000000407","journal-title":"Eye Contact Lens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.03.033","article-title":"Increased frequency of topical steroids provides benefit in patients with recalcitrant postsurgical macular edema","volume":"178","author":"Campochiaro PA","year":"2017","unstructured":"Campochiaro PA, Han YS, Mir TA, et al.. Increased frequency of topical steroids provides benefit in patients with recalcitrant postsurgical macular edema. Am J Ophthalmol. 2017, 178:163-75. 10.1016\/j.ajo.2017.03.033","journal-title":"Am J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310324","article-title":"Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey","volume":"101","author":"Aptel F","year":"2017","unstructured":"Aptel F, Colin C, Kaderli S, Deloche C, Bron AM, Stewart MW, Chiquet C. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol. 2017, 101:1-10. 10.1136\/bjophthalmol-2017-310324","journal-title":"Br J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3282f30577","article-title":"Perioperative antibiotics and anti-inflammatory agents in cataract surgery","volume":"19","author":"DeCroos FC","year":"2008","unstructured":"DeCroos FC, Afshari NA. Perioperative antibiotics and anti-inflammatory agents in cataract surgery. Curr Opin Ophthalmol. 2008, 19:22-6. 10.1097\/ICU.0b013e3282f30577","journal-title":"Curr Opin Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2011.592260","article-title":"Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema","volume":"19","author":"Sreekantam S","year":"2011","unstructured":"Sreekantam S, Denniston AK, Murray PI. Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema. Ocul Immunol Inflamm. 2011, 19:353-7. 10.3109\/09273948.2011.592260","journal-title":"Ocul Immunol Inflamm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S47569","article-title":"Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions","volume":"8","author":"Grob SR","year":"2014","unstructured":"Grob SR, Gonzalez-Gonzalez LA, Daly MK. Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions. Clin Ophthalmol. 2014, 8:1281-9. 10.2147\/OPTH.S47569","journal-title":"Clin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-013-0020-5","article-title":"Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?","volume":"2","author":"Pleyer U","year":"2013","unstructured":"Pleyer U, Ursell PG, Rama P. Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?. Ophthalmol Ther. 2013, 2:55-72. 10.1007\/s40123-013-0020-5","journal-title":"Ophthalmol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12660","article-title":"Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study","volume":"55","author":"Sheppard JD","year":"2014","unstructured":"Sheppard JD, Toyos MM, Kempen JH, Kaur P, Foster CS. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study. Invest Ophthalmol Vis Sci. 2014, 55:2993-3002. 10.1167\/iovs.13-12660","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1407433","article-title":"Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: pooled efficacy analysis of two phase 3 studies","volume":"27","author":"Sheppard JD","year":"2019","unstructured":"Sheppard JD, Foster CS, Toyos MM, Markwardt K, Da Vanzo R, Flynn TE, Kempen JH. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: pooled efficacy analysis of two phase 3 studies. Ocul Immunol Inflamm. 2019, 27:484-96. 10.1080\/09273948.2017.1407433","journal-title":"Ocul Immunol Inflamm"},{"key":"ref11","unstructured":"Difluprednate medical review clinical trial 002A & 002B. (2008). Accessed. April 21, 2019: http:\/\/www. accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022212s000_MedR.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2008.09.024","article-title":"Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain","volume":"35","author":"Korenfeld MS","year":"2009","unstructured":"Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009, 35:26-34. 10.1016\/j.jcrs.2008.09.024","journal-title":"J Cataract Refract Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/21690.9035","article-title":"To study the efficacy of difluprednate ophthalmic emulsion and prednisolone acetate ophthalmic suspension on post-operative inflammation in cataract surgery","volume":"10","author":"Garg P","year":"2016","unstructured":"Garg P, Tuteja N, Qayum S. To study the efficacy of difluprednate ophthalmic emulsion and prednisolone acetate ophthalmic suspension on post-operative inflammation in cataract surgery. J Clin Diagn Res. 2016, 10:NC05-8. 10.7860\/JCDR\/2016\/21690.9035","journal-title":"J Clin Diagn Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-017-0127-2","article-title":"Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednate","volume":"7","author":"Mercado-Sesma A","year":"2017","unstructured":"Mercado-Sesma A, Contreras-Rubio A, Baiza-Dur\u00e1n L, Olvera-Monta\u00f1o O, Miranda-Robles M, Bonilla-Garc\u00eda J. Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednate. J Ophthalmic Inflamm Infect. 2017, 7:10. 10.1186\/s12348-017-0127-2","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.35841\/clinical-ophthalmology.3.1.104-107","article-title":"Comparison of difluprednate 0.05% versus prednisolone acetate 1% eye drops following uneventful cataract surgery","volume":"2","author":"Saman IS","year":"2018","unstructured":"Saman IS, Mostafa EM, Kamel AG, Mohammed OA. Comparison of difluprednate 0.05% versus prednisolone acetate 1% eye drops following uneventful cataract surgery. J Clin Ophthalmol. 2018, 2:101-4. 10.35841\/clinical-ophthalmology.3.1.104-107","journal-title":"J Clin Ophthalmol"},{"key":"ref16","unstructured":"Sirion Therapeutics announces FDA approval of Durezol for treatment of postoperative ocular inflammation and pain. (2008). Accessed. April 21, 2019: https:\/\/www.biospace.com\/article\/releases\/sirion-therapeutics-announces-fda-approval-of-durezol-tm-for-treatment-of-p...."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.132","article-title":"Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study","volume":"30","author":"Wilson ME","year":"2016","unstructured":"Wilson ME, O'Halloran H, VanderVeen D, et al.. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2016, 30:1187-94. 10.1038\/eye.2016.132","journal-title":"Eye (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2011.47.5.1590791","article-title":"Difluprednate for inflammatory eye disorders","volume":"47","author":"Mulki L","year":"2011","unstructured":"Mulki L, Foster CS. Difluprednate for inflammatory eye disorders. Drugs Today (Barc). 2011, 47:327-33. 10.1358\/dot.2011.47.5.1590791","journal-title":"Drugs Today (Barc)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s4031","article-title":"Foveal thickness after phacoemulsification as measured by optical coherence tomography","volume":"2","author":"Georgopoulos GT","year":"2008","unstructured":"Georgopoulos GT, Papaconstantinou D, Niskopoulou M, Moschos M, Georgalas I, Koutsandrea C. Foveal thickness after phacoemulsification as measured by optical coherence tomography. Clin Ophthalmol. 2008, 2:817-20. 10.2147\/opth.s4031","journal-title":"Clin Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S28151","article-title":"Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate","volume":"6","author":"Chalam K","year":"2012","unstructured":"Chalam K, Khetpal V, Patel CJ. Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate. Clin Ophthalmol. 2012, 6:155-8. 10.2147\/OPTH.S28151","journal-title":"Clin Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S254705","article-title":"Difluprednate 0.05% versus prednisolone acetate post-phacoemulsification for inflammation and pain: an efficacy and safety clinical trial","volume":"14","author":"Palacio-Pastrana C","year":"2020","unstructured":"Palacio-Pastrana C, Ch\u00e1vez-Mondrag\u00f3n E, Soto-G\u00f3mez A, et al.. Difluprednate 0.05% versus prednisolone acetate post-phacoemulsification for inflammation and pain: an efficacy and safety clinical trial. Clin Ophthalmol. 2020, 14:1581-9. 10.2147\/OPTH.S254705","journal-title":"Clin Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0886-3350(96)80046-0","article-title":"Topical versus peribulbar anesthesia in clear corneal cataract surgery","volume":"22","author":"Zehetmayer M","year":"1996","unstructured":"Zehetmayer M, Radax U, Skorpik C, Menapace R, Schemper M, Weghaupt H, Scholz U. Topical versus peribulbar anesthesia in clear corneal cataract surgery. J Cataract Refract Surg. 1996, 22:480-4. 10.1016\/s0886-3350(96)80046-0","journal-title":"J Cataract Refract Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7820971","article-title":"Severity classification of conjunctival hyperaemia by deep neural network ensembles","volume":"2019","author":"Masumoto H","year":"2019","unstructured":"Masumoto H, Tabuchi H, Yoneda T, Nakakura S, Ohsugi H, Sumi T, Fukushima A. Severity classification of conjunctival hyperaemia by deep neural network ensembles. J Ophthalmol. 2019, 2019:7820971. 10.1155\/2019\/7820971","journal-title":"J Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198204000-00010","article-title":"Alkali burns of the eye: pathophysiology and treatment","volume":"75","author":"Pfister RR","year":"1982","unstructured":"Pfister RR, Koski J. Alkali burns of the eye: pathophysiology and treatment. South Med J. 1982, 75:417-22. 10.1097\/00007611-198204000-00010","journal-title":"South Med J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs DA","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005, 140:509-16. 10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S53223","article-title":"Retinal thickness changes after phacoemulsification","volume":"7","author":"Pardianto G","year":"2013","unstructured":"Pardianto G, Moeloek N, Reveny J, Wage S, Satari I, Sembiring R, Srisamran N. Retinal thickness changes after phacoemulsification. Clin Ophthalmol. 2013, 7:2207-14. 10.2147\/OPTH.S53223","journal-title":"Clin Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026752","article-title":"Difluprednate versus prednisolone acetate after cataract surgery: a systematic review and meta-analysis","volume":"9","author":"KhalafAllah MT","year":"2019","unstructured":"KhalafAllah MT, Basiony A, Salama A. Difluprednate versus prednisolone acetate after cataract surgery: a systematic review and meta-analysis. BMJ Open. 2019, 9:e026752. 10.1136\/bmjopen-2018-026752","journal-title":"BMJ Open"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S121849","article-title":"A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%","volume":"10","author":"Kusne Y","year":"2016","unstructured":"Kusne Y, Kang P, Fintelmann RE. A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%. Clin Ophthalmol. 2016, 10:2329-36. 10.2147\/OPTH.S121849","journal-title":"Clin Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S237405","article-title":"Measuring anterior chamber inflammation after cataract surgery: a review of the literature focusing on the correlation with cystoid macular edema","volume":"14","author":"De Maria M","year":"2020","unstructured":"De Maria M, Iannetta D, Cimino L, Coassin M, Fontana L. Measuring anterior chamber inflammation after cataract surgery: a review of the literature focusing on the correlation with cystoid macular edema. Clin Ophthalmol. 2020, 14:41-52. 10.2147\/OPTH.S237405","journal-title":"Clin Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50471-therapeutic-efficacy-of-difluprednate-005-versus-prednisolone-acetate-1-in-controlling-inflammation-and-macular-oedema-following-phacoemulsification-an-optical-coherence-tomography-based-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:58Z","timestamp":1707506878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50471-therapeutic-efficacy-of-difluprednate-005-versus-prednisolone-acetate-1-in-controlling-inflammation-and-macular-oedema-following-phacoemulsification-an-optical-coherence-tomography-based-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,25]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.14673","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,25]]}}}